Senior insider sale
Chief Scientific Officer at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$40.48M
1.76M shares
ROBINS HARLAN S plans to sell 1.76M shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $40.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Acquired as compensation -- Stock Options
Compensation -- Cashless exercise / same-day sale
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2022 | Acquired as compensation -- Stock Options Compensation -- Cashless exercise / same-day sale | 215.63K | — |
| Total | 215.63K | ||
Completed
Units to sell
261.04K
Market value
$6.41M
Units to sell
152.04K
Market value
$3.77M
Units to sell
148.96K
Market value
$3.69M
Units to sell
207.60K
Market value
$4.54M
Units to sell
284.80K
Market value
$6.23M
Units to sell
250K
Market value
$5.57M
Units to sell
136.24K
Market value
$2.94M
Units to sell
6.16K
Market value
$110.9K
Units to sell
100K
Market value
$1.74M
Planned — Approximate Date
Units to sell
215.63K
Market value
$5.50M
Units
1.76M
Value
$40.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/18/2026 | 261.04K | $6.41M | — | Completed |
8/17/2026 | 152.04K | $3.77M | — | Completed |
8/17/2026 | 148.96K | $3.69M | — | Completed |
7/21/2026 | 207.60K | $4.54M | — | Completed |
7/21/2026 | 284.80K | $6.23M | — | Completed |
7/2/2026 | 250K | $5.57M | — | Completed |
7/2/2026 | 136.24K | $2.94M | — | Completed |
6/16/2026 | 6.16K | $110.9K | — | Completed |
6/15/2026 | 100K | $1.74M | — | Completed |
| Planned — Approximate Date | ||||
8/19/2026 | 215.63K | $5.50M | NASD | Planned |
| Total | 1.76M | $40.48M | ||